Taiyen Biotech Co

Taiyen Biotech Co EBIT Margin

The EBIT Margin (Operating Margin) of Taiyen Biotech Co (1737.TW) as of Oct 27, 2026 is 14.34 %. In the previous year, EBIT Margin (Operating Margin) was 13.50 % — a change of 6.19% (higher).

EBIT Margin

14.34 %

YoY

6.19%

Last updated:

EBIT Margin (Operating Margin) of Taiyen Biotech Co is 2025 14.34 % . EBIT Margin (Operating Margin) of Taiyen Biotech Co was 2024 13.50 % . It decreases by 6.19% higher compared to the previous year.

Taiyen Biotech Co's operating (EBIT) margin stands at 14.3%, up from 12.6% several years earlier.

The Taiyen Biotech Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
13.94 TWD
Jan 1, 2019
14.83 TWD
Jan 1, 2020
14.94 TWD
Jan 1, 2021
12.60 TWD
Jan 1, 2022
14.81 TWD
Jan 1, 2023
9.27 TWD
Jan 1, 2024
13.50 TWD
Jan 1, 2025
14.34 TWD
The Taiyen Biotech Co EBIT Margin history
YEAREBIT MarginYoY
14.34 %+6.19%
13.50 %+45.63%
9.27 %-37.40%
14.81 %+17.57%
12.60 %-15.69%
14.94 %+0.76%
14.83 %+6.33%
13.94 %-8.05%
15.16 %+1.95%
14.87 %+32.79%
11.20 %+76.36%
6.35 %+15,309.17%
0.04 %+97.45%
0.02 %-79.15%
0.10 %-6.04%
0.11 %-6.72%
0.11 %-1.22%
0.12 %+99.76%
0.06 %-40.98%
0.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Taiyen Biotech Co Stock analysis

What does Taiyen Biotech Co do? Taiyen Biotech Co Ltd is a Taiwanese company specializing in the development of food ingredients and biologically active substances. It was founded in 2002 by Dr. Yau-Lin Tseng, a renowned food chemist. Since its founding, Taiyen Biotech has developed and launched a wide range of products and services. The company focuses on the production of dietary supplements and functional foods that are intended to improve health and well-being. The business strategy of Taiyen Biotech is to produce innovative and scientifically supported products that meet the needs of customers. The company relies on intensive research and development to constantly improve its products and explore new markets. It collaborates closely with other industry, science, and technology partners. One of the most well-known divisions of Taiyen Biotech is the production of fermented dietary supplements based on microorganisms. The company has developed a series of innovative products that contain high concentrations of live bacterial cultures and are targeted towards various health needs and issues. Some of Taiyen Biotech's most famous products include food additives like Lactobacillus acidophilus-Lafti®L10, probiotic bacteria that support the immune system and inhibit the growth of pathogenic bacteria. Another product is Hydroxytyrosol, an antioxidant derivative of acetic acid that is used to combat oxidative stress and prevent chronic diseases such as cancer and cardiovascular diseases. Taiyen Biotech also offers services in the field of biotechnology, including the development of fermentation processes, the production of plant and animal cell cultures, and the manufacturing of enzymes and bioactive compounds. The products of Taiyen Biotech are distributed in many countries worldwide, including the USA, Europe, Asia, and Australia. The company is ISO 22000 certified and has received international certificates and recognition for its products and services. Overall, Taiyen Biotech has experienced high growth in recent years and has become a significant player in the global market for food ingredients and biologically active compounds. The company aims to further strengthen its market presence in the coming years and develop innovative products that meet the needs of customers. Taiyen Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Taiyen Biotech Co stock

EBIT Margin (Operating Margin) of Taiyen Biotech Co is 14.34 % in 2025.

EBIT Margin (Operating Margin) of Taiyen Biotech Co changed from 13.50 % to 14.34 %, representing a 6.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Taiyen Biotech Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Taiyen Biotech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Taiyen Biotech Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Taiyen Biotech Co